202 related articles for article (PubMed ID: 25084201)
1. Polymorphisms in genes involved in the mechanism of action of methotrexate: are they associated with outcome in rheumatoid arthritis patients?
Salazar J; Moya P; Altés A; Díaz-Torné C; Casademont J; Cerdà-Gabaroi D; Corominas H; Baiget M
Pharmacogenomics; 2014 Jun; 15(8):1079-90. PubMed ID: 25084201
[TBL] [Abstract][Full Text] [Related]
2. Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.
Milic V; Jekic B; Lukovic L; Bunjevacki V; Milasin J; Novakovic I; Damnjanovic T; Popovic B; Maksimovic N; Damjanov N; Radunovic G; Pejnovic N; Krajinovic M
Clin Exp Rheumatol; 2012; 30(2):178-83. PubMed ID: 22324981
[TBL] [Abstract][Full Text] [Related]
3. Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.
Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R
Biomed Res Int; 2014; 2014():368681. PubMed ID: 24967362
[TBL] [Abstract][Full Text] [Related]
4. ATIC missense variant affects response to methotrexate treatment in rheumatoid arthritis patients.
Kurzawski M; Malinowski D; Szarmach N; Nowak A; Goryniak A; Pawlik A; Droździk M
Pharmacogenomics; 2016 Dec; 17(18):1971-1978. PubMed ID: 27885916
[TBL] [Abstract][Full Text] [Related]
5. Association of the ATIC 347 C/G polymorphism with responsiveness to and toxicity of methotrexate in rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC
Rheumatol Int; 2016 Nov; 36(11):1591-1599. PubMed ID: 27379764
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
7. Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis.
Weisman MH; Furst DE; Park GS; Kremer JM; Smith KM; Wallace DJ; Caldwell JR; Dervieux T
Arthritis Rheum; 2006 Feb; 54(2):607-12. PubMed ID: 16447238
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.
Malik F; Ranganathan P
Pharmacogenomics; 2013 Feb; 14(3):305-14. PubMed ID: 23394392
[TBL] [Abstract][Full Text] [Related]
9. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.
Takatori R; Takahashi KA; Tokunaga D; Hojo T; Fujioka M; Asano T; Hirata T; Kawahito Y; Satomi Y; Nishino H; Tanaka T; Hirota Y; Kubo T
Clin Exp Rheumatol; 2006; 24(5):546-54. PubMed ID: 17181924
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
Owen SA; Hider SL; Martin P; Bruce IN; Barton A; Thomson W
Pharmacogenomics J; 2013 Jun; 13(3):227-34. PubMed ID: 22450926
[TBL] [Abstract][Full Text] [Related]
12. ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
Muralidharan N; Mariaselvam CM; Jain VK; Gulati R; Negi VS
Pharmacogenomics; 2016 Feb; 17(3):241-8. PubMed ID: 26799664
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
14. ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma.
Park JA; Shin HY
J Pediatr Hematol Oncol; 2017 Jul; 39(5):e270-e274. PubMed ID: 28267080
[TBL] [Abstract][Full Text] [Related]
15. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
Lee YC; Cui J; Costenbader KH; Shadick NA; Weinblatt ME; Karlson EW
Rheumatology (Oxford); 2009 Jun; 48(6):613-7. PubMed ID: 19193698
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure.
Fransen J; Kooloos WM; Wessels JA; Huizinga TW; Guchelaar HJ; van Riel PL; Barrera P
Pharmacogenomics; 2012 Jul; 13(9):1087-94. PubMed ID: 22838954
[TBL] [Abstract][Full Text] [Related]
17. A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis.
Wessels JA; van der Kooij SM; le Cessie S; Kievit W; Barerra P; Allaart CF; Huizinga TW; Guchelaar HJ;
Arthritis Rheum; 2007 Jun; 56(6):1765-75. PubMed ID: 17530705
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms and pharmacogenomics for the toxicity of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic review and meta-analysis.
Qiu Q; Huang J; Lin Y; Shu X; Fan H; Tu Z; Zhou Y; Xiao C
Medicine (Baltimore); 2017 Mar; 96(11):e6337. PubMed ID: 28296761
[TBL] [Abstract][Full Text] [Related]
19. Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.
Chaabane S; Marzouk S; Akrout R; Ben Hamad M; Achour Y; Rebai A; Keskes L; Fourati H; Bahloul Z; Maalej A
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):385-93. PubMed ID: 26077125
[TBL] [Abstract][Full Text] [Related]
20. MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.
Owen SA; Lunt M; Bowes J; Hider SL; Bruce IN; Thomson W; Barton A
Pharmacogenomics J; 2013 Apr; 13(2):137-47. PubMed ID: 21931346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]